The Next Generation of RTSM: Introducing Atreo v2.2

In the fast-paced world of clinical trials, Agile RTSM is the difference between a medical breakthrough and a technical bottleneck. At Atreo, our vision has always been to lead the next generation of Randomization and Trial Supply Management. With the launch of Atreo v2.2, we continue to deliver on that promise by providing a platform where quality and speed coexist to drive meaningful clinical outcomes.

Why Agile RTSM Matters in Modern Clinical Trials

Traditional RTSM systems are often rigid, requiring weeks of costly change orders for simple adjustments. Atreo is designed to be different. By committing to multiple core product releases annually, we ensure a "continuous rebirth" of features. This ensures your study teams always benefit from a modern, simplified experience rather than struggling with legacy tech.

Advanced Cohort Management and Sponsor Empowerment

Trial designs are becoming increasingly complex. Our Enhanced Dynamic Cohort Management features allow for greater flexibility in subject grouping, ensuring intricate protocols are executed with precision. Furthermore, we are empowering sponsors with a new Kit Upload Feature. Sponsors can now load kit lists directly into their RTSM system, removing middlemen and expediting timelines from manufacturing to site availability.

Localization and Predictive Logistics

Global trials face unique local challenges. v2.2 introduces enhanced Country-Specific Options to support varying lead time requirements. By tailoring predictive parameters to specific regions, Atreo helps logistics teams navigate the nuances of international shipping and regulatory timelines with ease.

Key Features of the Atreo v2.2 Release

• Customizable Training Modules: Sponsor-configured, role-based training ensures site staff receive instructions tailored to their specific responsibilities.
• Data Integrity & Automated Workflows: Expanded automated data change capabilities, including configurable reminders and more granular IP status advancements.
• Studio Configuration & Scalability: Real-time views allow for automated checks during the build process, ensuring high-quality, scalable deployments.

The release of v2.2 isn't just an upgrade—it's a reflection of our dedication to your success. By focusing on ease of use and continuous innovation, Atreo ensures that your clinical trial technology is an asset, not a hurdle. Ready to see the next generation of Agile RTSM in action?